BCHMF (Bachem Holding AG) 5-Year Yield-on-Cost %: 1.87 (As of Jul. 08, 2026) — Near Median


BCHMF Bachem Holding AG BCHMF
96 GF Score
Price $87.34
GF Value $97.99
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Bachem Holding AG 5-Year Yield-on-Cost %?

Bachem Holding AG BCHMF 96 5-Year Yield-on-Cost % is 1.87 as of Jul. 08, 2026, which is 5% above its 10-year median of 1.78. GuruFocus rates BCHMF with a GF Score™ of 96/100 and a GF Value™ of $97.99 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 153 Biotechnology companies, Bachem Holding AG ranks better than 50.33% on this metric.

Bachem Holding AG's yield on cost for the quarter that ended in Dec. 2025 was 1.87.


The historical rank and industry rank for Bachem Holding AG's 5-Year Yield-on-Cost % or its related term are showing as below:

BCHMF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.51   Med: 1.78   Max: 3.91
Current: 1.87


During the past 13 years, Bachem Holding AG's highest Yield on Cost was 3.91. The lowest was 0.51. And the median was 1.78.


BCHMF's 5-Year Yield-on-Cost % is ranked better than
50.33% of 153 companies
in the Biotechnology industry
Industry Median: 1.64 vs BCHMF: 1.87

Bachem Holding AG  (OTCPK:BCHMF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Bachem Holding AG 5-Year Yield-on-Cost % Related Terms


BCHMF vs VRTX, REGN, ALNY: 5-Year Yield-on-Cost % Comparison

For the Biotechnology subindustry, Bachem Holding AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bachem Holding AG 5-Year Yield-on-Cost % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bachem Holding AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Bachem Holding AG's 5-Year Yield-on-Cost % falls into.


BCHMF
96GF Score
Bachem Holding AG BCHMF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bachem Holding AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Bachem Holding AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 1.87 mean?
Bachem Holding AG (BCHMF) has a 5-Year Yield-on-Cost % of 1.87 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bachem Holding AG and its competitors. This is near median its historical median of 1.78. Over the past decade, Bachem Holding AG's 5-Year Yield-on-Cost % has ranged from 0.51 to 3.91. According to the industry distribution chart, Bachem Holding AG ranks #76 out of 153 companies in the Biotechnology industry, placing it in the top 49.7%.
Is Bachem Holding AG's 5-Year Yield-on-Cost % too high?
Bachem Holding AG's current 5-Year Yield-on-Cost % of 1.87 is near median its 10-year median of 1.78. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 3.91. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.64. Bachem Holding AG's value of 1.87 is 14% above this industry median. Based on the distribution chart, Bachem Holding AG ranks #76 out of 153 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bachem Holding AG has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #76 out of 153 companies for 5-Year Yield-on-Cost %. This puts Bachem Holding AG in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 1.64. Bachem Holding AG's value of 1.87 is 14% above this benchmark. Historically, Bachem Holding AG's own 5-Year Yield-on-Cost % has ranged from 0.51 to 3.91 over the past decade. While the company's 10-year median is 1.78 vs. the industry median of 1.64, Bachem Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.64, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bachem Holding AG's current 5-Year Yield-on-Cost % of 1.87 is 14% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bachem Holding AG and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bachem Holding AG's current 5-Year Yield-on-Cost % is 1.87, which is near median its own 10-year median of 1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $97.99, compared to a current price of $87.34 — trading 10.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.87, which is near median its 10-year median of 1.78 and 14% above the Biotechnology industry median of 1.64. Bachem Holding AG's overall GF Score™ is 96/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current 5-Year Yield-on-Cost % is 1.87 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bachem Holding AG (BCHMF) Overvalued in 2026?

Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued. The current stock price of $87.34 is trading 10.9% below its estimated GF Value™ of $97.99. GuruFocus considers Bachem Holding AG to be Modestly Undervalued.

Key valuation signals for BCHMF:

  • 5-Year Yield-on-Cost %: 1.87 (near median its 10-year median of 1.78)
  • GF Value™: $97.99 vs. price of $87.34 (10.9% below fair value)
  • GF Score™: 96/100 with 9 warning signs
  • Industry Position: 14% above the Biotechnology median (#76 of 153)

No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bachem Holding AG Business Description

Address Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
96GF Score

Get the complete analysis for BCHMF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$87.34
Price
$97.99
GF Value